Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Leitner

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Wiener Klinische Wochenschrift|December 5, 2013
[Mag. Dr. Judith Leitner: Medical University of Vienna Researcher of the Month, October 2013]Judith Leitner
Methods in Molecular Biology (Clifton, N.J.)|September 30, 2025
Evaluation of Immune Checkpoint Inhibitors in a Jurkat-Based Transcriptional Reporter System: A Cell-Based Reporter Platform for Evaluation of Immune Checkpoint InhibitorsMagdalena Bojko, Judith Leitner, Peter Steinberger
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 19, 2024
LAG-3-An incompletely understood target in cancer therapyJudith Leitner, Katharina Aigner-Radakovics, Peter Steinberger
Immunology Letters|November 28, 2009
Receptors and ligands implicated in human T cell costimulatory processesJudith Leitner, Katharina Grabmeier-Pfistershammer, Peter Steinberger
European Journal of Immunology|May 6, 2021
PD-1 blocking antibodies moonlighting as killersJudith Leitner, Claire Battin, Katharina Grabmeier-Pfistershammer, et al.
Cancer Immunology, Immunotherapy : CII|July 24, 2019
CTLA-4 antibody ipilimumab negatively affects CD4<sup>+</sup> T-cell responses in vitroSandra Rosskopf, Judith Leitner, Gerhard J Zlabinger, et al.
Biochemical Pharmacology|March 9, 2026
Evaluation of small molecule PD-1/PD-L1 inhibitors in a T cell reporter systemJudith Leitner, Helene Schindler, Simon Gumpelmair, et al.
Iscience|March 8, 2024
Transcriptional reprogramming via signaling domains of CD2, CD28, and 4-1BBAnnika De Sousa Linhares, Sumana Sharma, Peter Steinberger, et al.
Frontiers in Immunology|September 21, 2018
Not All Immune Checkpoints Are Created EqualAnnika De Sousa Linhares, Judith Leitner, Katharina Grabmeier-Pfistershammer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2010
Identification of PD-1 as a unique marker for failing immune reconstitution in HIV-1-infected patients on treatmentKatharina Grabmeier-Pfistershammer, Peter Steinberger, Armin Rieger, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Wiener Klinische Wochenschrift|December 5, 2013
[Mag. Dr. Judith Leitner: Medical University of Vienna Researcher of the Month, October 2013]Judith Leitner
Methods in Molecular Biology (Clifton, N.J.)|September 30, 2025
Evaluation of Immune Checkpoint Inhibitors in a Jurkat-Based Transcriptional Reporter System: A Cell-Based Reporter Platform for Evaluation of Immune Checkpoint InhibitorsMagdalena Bojko, Judith Leitner, Peter Steinberger
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 19, 2024
LAG-3-An incompletely understood target in cancer therapyJudith Leitner, Katharina Aigner-Radakovics, Peter Steinberger
Immunology Letters|November 28, 2009
Receptors and ligands implicated in human T cell costimulatory processesJudith Leitner, Katharina Grabmeier-Pfistershammer, Peter Steinberger
European Journal of Immunology|May 6, 2021
PD-1 blocking antibodies moonlighting as killersJudith Leitner, Claire Battin, Katharina Grabmeier-Pfistershammer, et al.
Cancer Immunology, Immunotherapy : CII|July 24, 2019
CTLA-4 antibody ipilimumab negatively affects CD4<sup>+</sup> T-cell responses in vitroSandra Rosskopf, Judith Leitner, Gerhard J Zlabinger, et al.
Biochemical Pharmacology|March 9, 2026
Evaluation of small molecule PD-1/PD-L1 inhibitors in a T cell reporter systemJudith Leitner, Helene Schindler, Simon Gumpelmair, et al.
Iscience|March 8, 2024
Transcriptional reprogramming via signaling domains of CD2, CD28, and 4-1BBAnnika De Sousa Linhares, Sumana Sharma, Peter Steinberger, et al.
Frontiers in Immunology|September 21, 2018
Not All Immune Checkpoints Are Created EqualAnnika De Sousa Linhares, Judith Leitner, Katharina Grabmeier-Pfistershammer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2010
Identification of PD-1 as a unique marker for failing immune reconstitution in HIV-1-infected patients on treatmentKatharina Grabmeier-Pfistershammer, Peter Steinberger, Armin Rieger, et al.
Pageof 8